A recent whole-genome sequencing study of pancreas neuroendocrine tumors suggested that sporadic neuroendocrine tumors contain an elevated proportion of germline mutations in the DNA repair genes MUTYH, CHEK2, and BRCA226. This evidence concerns the gene CHEK2 and neuroendocrine neoplasm.